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Traditionally, the management of infants with Fallot’s tetralogy (TOF) with excessively reduced 
pulmonary flow and cyanosis has been palliation until or unless complete repair is feasible. Palliation 
involves a procedure that augments pulmonary flow. 
 
Most series recognise two subgroups of patients at high risk even in the current era: the cyanotic 
neonate/infant with small pulmonary arteries and those with complex anatomical variants of tetralogy 
and/or significant comorbidities such as additional congenital heart lesions (e.g associated Atrio 
Ventricular Septal Defect) or other congenital anomalies. There is an argument for palliation of these 
high-risk groups to allow for future potentially more effective elective repair.1 
 
Palliation in such cases has traditionally been by surgery, usually in the form of a surgical systemic 
to pulmonary shunt, such as a Blalock-Taussig (BT) or, less commonly, a limited right ventricular 
outflow (RVOT) patch. More recently, catheter interventions have played an alternative role by 
stenting the arterial duct (PDA) or the right ventricular outflow tract.2,3 
Ballooning of the right ventricular outflow tract is no longer practiced as the composite obstruction 
in TOF demands a device to support the dynamic obstruction.   
 
Transcatheter stenting of the arterial duct carries relatively low risk but may actually result in 
significant morbidity and mortality including pulmonary artery deformation/stenosis and shunt 
obstruction.4 Moreover, it is less feasible to achieve controlled blood flow to the lungs and the PDA 
trajectory and shape can cause technical problems. 
 
Transcatheter stenting of the RVOT5 is gaining popularity as this results in a more physiological 
haemodynamic result and encourages equal growth of small pulmonary arteries providing a better 
surgical substrate for subsequent repair.6 
 
We present two Maltese babies who required early intervention using an RVOT stent and performed 
10 years apart. Case 1 is a preterm baby (gestation 31/40) with TOF who required intervention due 
to increasing desaturation. Case 2 was performed in January 2005 and will be discussed later. 
 
Case 1: One of twins with a birth weight of 1.25 kg born at 31 weeks gestation. She showed 
progressively deteriorating saturations despite propranolol at five weeks of age when she weighed 
1.9 kg. The echocardiogram confirmed the diagnosis of situs solitus with Fallot’s tetralogy. 
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The pulmonary valve was very small and dysplastic but with a dynamic sub-pulmonary component. 
Catheterisation was carried out under GA entering the femoral vein percutaneously with a 4Fr 
Terumo Glidesheath. After haemodynamics and angiography (figures 1 and 2), the RVOT was 
measured at approximately 2-3mm by 10-11mm (figures 3-5). The RVOT was crossed with a 
Whisper 0.014” wire and a Judkins right guide catheter placed in the RVOT through which a Biotronik 
Pro-Kinetic 3.0x13mm stent was placed having pre-dilated the pulmonary valve due to resistance 
crossing this with the guide catheter or the stent. Deployment was done during apnoea to reduce 
movement but this also helps to ensure that all the team is engaged during this critical point of the 
procedure. The saturations improved immediately to the mid-90s % and there were no complications. 
Aspirin was commenced at 5 mg/Kg/day. 
 
Figure 1: RV Angiogram in AP/Cranial 25 degrees showing Fallot’s tetralogy with composite 
RVOTO and a right aortic arch. 
 
 
Figure 2: LV Angiogram in long axial view showing Fallot’s tetralogy with a single VSD and 
aortic override. 
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Figure 3: RVOT measurement 
 
 
Figure 4: RVOT measurement 
 
 
Figure 5: RVOT measurement 
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The stent was prepared (figure 6) inflated above nominal burst pressure giving an estimated diameter 
of 3.5mm due to the semi-compliant balloon (figures 7 and 8). As the pulmonary annulus was very 
hypoplastic and reparative surgery must entail a trans-annular patch, the stent covered the pulmonary 
valve as well as the infundibulum. When possible, the pulmonary valve should be preserved. 
 
Figure 6: Stent prepared across RVOT 
 
 
Figure 7: Stent inflated across RVOT 
 
 
Figure 8: Post-procedure angiogram. 
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The echocardiographic appearance of the stent is shown in figures 9 and 10. 
 
Figure 9: Echocardiographic appearance of stented RVOT in apical four chamber view. 
 
 
Figure 10: Echocardiographic appearance of stented RVOT in parasternal short axis view. 
 
 
This stent will allow the baby to grow into a suitable weight for eventual Fallot surgery. Aspirin 
5mg/kg/day was commenced, the baby was discharged home with a saturation of 80% off 
propranolol. If the patient develops cyanosis again during the follow up clinic he will be referred for 
reparative surgery if the weight and anatomy are suitable otherwise he may require dilatation of the 
current stent with the possibility of the addition of a second stent if the muscular obstruction extends 
below the bottom of the stent. 
 
 
 
 
Case 2: This was a male baby who was born in November 2004 at 36 weeks of gestation, small for 
gestational age. He had Fallot’s tetralogy, a left aortic arch, left superior vena cava to coronary sinus 
and additional problems. These included omphalocele (see CXR, figure 11), a left inguinal hernia 
and talipes equinovarus.  
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Figure 11: Chest and abdominal x-ray showing large omphalocele 
 
 
Karyotype was normal. He was catheterised at seven weeks of age due to increasing cyanosis; the 
latter was in part related to small lungs which became compressed after repair of the omphacoele but 
there was progressive worsening of the RVOTO.  Weight was 3kg. Access was extremely technically 
difficult. Standard percutaneous approach on both groins failed and a cut down to the right femoral 
vein showed that this was fibrosed. Similarly, right subclavian vein and right internal jugular 
approaches failed. The superior vena cava was entered directly and a stent (Biodivisio 4x15 mm) 
across the RVOT decreased the gradient (peaks) from 90 to 55mmHg (figures 12-14). A Hickman 
line was left in place at the end of the procedure.  
  
Bugeja J, Grech V, DeGiovanni JV. Right ventricular outflow tract stenting – effective palliation for Fallot’s tetralogy. 
Images Paediatr Cardiol 2015;17(3):3-10. 
9 
 
 
Figure 12: Pre-stent angiogram. Arrow indicates site of RVOTO. 
 
 
Figure 13: Stent inflation across the RVOT. 
 
 
Figure 14: Post-stent angiogram. Arrow indicates site of stent implantation. 
 
 
The baby remained initially well but had episodes of repeated desaturation requiring ventilation, 
despite a patent stent. There were concerns with regard to ongoing sepsis, chronic lung disease with 
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poor lung function and this was explained to the family. An ultrasound of the brain one month later 
showed cortical atrophy with an interhemispheric fissure >1cm wide, a periventricular cyst of the 
right hemisphere and biventricular dilatation, almost certainly due to hypoxic ischaemic 
encephalopathy. After discussion with the parents, support was withdrawn and the patient passed 
away shortly after. 
 
In conclusion, RVOT stents provide a viable and logical alternative that is more haemodynamically 
physiological than traditional techniques, such as, shunts and arterial duct stenting, which are a 
haemodynamically equivalent procedure. 
 
Potential problems with RVOT stenting include RVOT rupture, stent embolisation to pulmonary 
artery or aorta, stent fracture/compression and in-growth stenosis. However, stenting the RVOT as 
palliation leaves a virgin field for the surgeon during repair and does not have the failure rate of a BT 
shunt which is around 8%. The eventual repair takes slightly longer but with no clinical implications. 
Whereas in 2005, RVOT stenting was carried out in desperate situations,7,8 these days several centres 
use it as their palliation of choice for infants with TOF who are not suitable for repair at the time of 
presentation.6 In very small infants, a jugular approach may be preferable as this vein is larger than 
the femoral. 
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